Veraxa Biotech Holding AG (VRXA) Non-Current Deferred Tax Liability (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $18.1 million in Q4 2025.

• On a quarterly basis, Non-Current Deferred Tax Liability rose 4.37% year-over-year to $18.1 million in Q4 2025; TTM through Dec 2025 was $18.1 million, a 4.37% increase from a year earlier, with the FY2025 full-year figure at $18.1 million, up 4.37% from the prior year.
• Non-Current Deferred Tax Liability for Q4 2025 stood at $18.1 million, up from $17.3 million in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for VRXA reached as high as $18.1 million in Q4 2025 and fell as low as $17.3 million in Q4 2024.